David Chipperfield
2023 Pritzker Prize Laureate | Founder, David Chipperfield Architects | Architecture, Cities & Civic Design
Sir Peter John Ratcliffe
2019 Nobel Laureate in Physiology or Medicine | Clinical Research Director, Francis Crick Institute | Pioneer of Oxygen-Sensing Biology
Sir Peter Ratcliffe's Nobel Prize-winning discovery of how cells sense oxygen has generated approved drugs and reshaped cancer biology, anemia treatment, and cardiovascular research. As Clinical Research Director at the Francis Crick Institute and a leading figure at Oxford, he brings unmatched scientific authority. Audiences gain rare insight into how decades of fundamental research translates into medicine that saves lives.
Want to book Sir Peter John Ratcliffe as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Sir Peter John Ratcliffe biography
Sir Peter Ratcliffe is a 2019 Nobel Laureate in Physiology or Medicine whose discovery of how cells detect and respond to oxygen levels has opened a new era in medicine. He is Clinical Research Director at the Francis Crick Institute in London, Director of the Target Discovery Institute at the University of Oxford, and a Fellow of the Royal Society. His work has reshaped our understanding of fundamental biology and given researchers a new set of molecular targets for treating cancer, anemia, cardiovascular disease, and a range of conditions driven by dysregulated oxygen sensing.
Science speaker Sir Peter Ratcliffe is best known for elucidating the molecular machinery of the hypoxia-inducible factor (HIF) pathway — the system cells use to sense falling oxygen levels and trigger adaptive responses including red blood cell production, metabolic reprogramming, and blood vessel formation. Working in parallel with William Kaelin Jr. at Harvard and Gregg Semenza at Johns Hopkins, Ratcliffe identified how the oxygen-regulated degradation of HIF-1α is controlled by prolyl hydroxylase enzymes, providing the mechanistic link between oxygen availability and gene expression. This discovery, recognized with the Nobel Prize jointly shared with Kaelin and Semenza, has already translated into a new class of approved drugs — HIF prolyl hydroxylase inhibitors — now used to treat anemia in patients with chronic kidney disease.
Science with Transformative Reach
Ratcliffe trained in medicine at Cambridge and Oxford before dedicating his career to understanding one of the most basic facts of biology: that all complex life depends on oxygen, and that cells must have exquisitely sensitive mechanisms for detecting when supply falls short. His lab’s work, conducted over three decades at Oxford and now continuing at the Crick, has produced insights that extend far beyond the original question. Researchers around the world are now investigating HIF-pathway interventions in oncology, where tumors exploit the same oxygen-sensing machinery to grow and metastasize, and the field has become one of the most productive areas of translational biomedicine.
Ratcliffe holds numerous honors beyond the Nobel, including the Lasker Award (shared with Kaelin and Semenza, 2016), the Gairdner International Award (2010), and election as a Fellow of the Academy of Medical Sciences. He was knighted for services to clinical medicine in 2014 — recognition of both his scientific output and his decades of commitment to patient-relevant research.
As a speaker, Sir Peter Ratcliffe offers audiences an authoritative and deeply human account of how fundamental science drives medical progress. He speaks compellingly on the process of scientific discovery — the patience, the failed hypotheses, the moments of unexpected clarity — and on how basic research in biology is now being translated into drugs that extend and improve lives. For pharmaceutical companies, medical congresses, biotech investors, academic institutions, and organizations committed to science-led innovation, Ratcliffe’s perspective is both intellectually galvanizing and practically relevant. Audiences leave with a deeper appreciation of what it means to pursue a question rigorously for decades, and what that commitment can ultimately deliver for patients worldwide.
Sir Peter John Ratcliffe Speaking Videos
Peter Ratcliffe - Elucidation of oxygen sensing pathways in human and animal cells
Nobel Lecture: Sir Peter J. Ratcliffe, Nobel Prize in Physiology or Medicine 2019
Sir Peter John Ratcliffe Keynote Topics
The discovery of the HIF oxygen-sensing pathway is one of the most consequential advances in modern biology. Ratcliffe traces the scientific journey from a basic research question — how do cells detect low oxygen? — to a mechanistic answer that has already produced approved drugs and is driving active development programs in oncology, anemia, and cardiovascular disease. A compelling account of how curiosity-driven science becomes clinical reality.
Drawing on his own career and the broader story of HIF-pathway drug development, Ratcliffe examines the journey from laboratory insight to approved treatment — and what it reveals about the infrastructure, patience, and collaboration required to make fundamental research clinically useful. Essential viewing for life sciences, pharma, and biotech audiences navigating their own translational challenges.
The oxygen-sensing pathway is now implicated in conditions ranging from tumor metastasis to ischemic heart disease to the biology of aging. Ratcliffe maps the frontier of hypoxia research and the therapeutic opportunities emerging from a deeper understanding of how cells and tissues manage oxygen stress — a forward-looking session for researchers, investors, and strategic leaders in the life sciences.
A reflective and personal keynote on what it takes to pursue a scientific question for decades, absorb setbacks, and ultimately arrive at something that changes medicine. Ratcliffe speaks candidly about the culture of research institutions, the role of failure in the scientific process, and what academic and corporate R&D leaders can learn from the long game of fundamental science.
Speaker topics
FAQs on Booking Sir Peter John Ratcliffe
Why Sir Peter Ratcliffe?
Booking Sir Peter Ratcliffe means bringing one of the world's most consequential living scientists to your stage. His Nobel Prize-winning discovery of the oxygen-sensing pathway isn't an abstract achievement — it has already produced approved drugs and is actively driving development pipelines in cancer, anemia, cardiovascular disease, and beyond. At the podium, Ratcliffe combines scientific authority with genuine clarity, making complex molecular biology accessible without sacrificing depth. He is an exceptional choice for pharmaceutical conferences, biotech summits, medical congresses, academic events, and any organization that wants to inspire its people with the power of patient, rigorous science. Contact Aurum Speakers Bureau to discuss availability and booking.
What did Sir Peter Ratcliffe win the Nobel Prize for?
Sir Peter Ratcliffe shared the 2019 Nobel Prize in Physiology or Medicine with William Kaelin Jr. and Gregg Semenza for discovering how cells sense and adapt to oxygen availability. Ratcliffe's contribution centered on identifying the molecular mechanism by which the HIF-1α protein is marked for degradation when oxygen is plentiful, and stabilized when oxygen is low. He showed that prolyl hydroxylase enzymes act as the oxygen-dependent switch — a discovery that explained for the first time exactly how cells "read" oxygen levels and mount a coordinated genetic response.
What is the HIF pathway and why does it matter for drug development?
The HIF (hypoxia-inducible factor) pathway is the cellular system that controls how genes respond when oxygen supply falls. When oxygen drops, HIF proteins accumulate and activate genes for red blood cell production, new blood vessel growth, and metabolic adaptation. In disease, this pathway is frequently dysregulated: cancer cells exploit HIF signaling to fuel their growth and spread, while patients with chronic kidney disease often have impaired HIF-driven red blood cell production. Understanding this pathway has enabled researchers to design drugs that either block HIF in tumors or activate it to treat anemia. HIF prolyl hydroxylase inhibitors — the first drugs to emerge from this work — are now approved in several countries for anemia in chronic kidney disease patients.
What topics does Nobel Prize speaker Sir Peter Ratcliffe cover?
Sir Peter Ratcliffe speaks on the science and medical implications of the oxygen-sensing pathway, including its role in cancer biology, anemia, and cardiovascular disease. He also addresses the broader themes of how fundamental research translates into clinical breakthroughs, the culture of scientific inquiry, and the long-term value of curiosity-driven investigation. His talks resonate deeply with audiences in life sciences, pharma, biotech, healthcare, and academic and research institutions. Aurum Speakers Bureau can tailor a keynote recommendation to your event's specific focus — contact us to discuss.
How to book Sir Peter John Ratcliffe as a keynote speaker?
Aurum Speakers Bureau can help you book Sir Peter John Ratcliffe as a speaker for your next event, conference, or board meeting. Simply fill out our contact form to inquire about Sir Peter John Ratcliffe's availability for a speaking engagement. One of our booking agents will respond to your request immediately and contact the speaker to let them know you want to hire them. We will assist you with obtaining speaking fees, booking information, and confirming availability for Sir Peter John Ratcliffe or any other top keynote speaker or celebrity of your choice.
How much is Sir Peter John Ratcliffe speaking fee?
Sir Peter John Ratcliffe speaking fees are determined by several factors, including the event's date, whether it's a virtual or in-person event, the duration, format, preparation required for their speech, and more. The same applies to the cost to hire any other top expert speakers and celebrities. The Speaker Fee Range listed on our website is simply a guideline and is subject to change without notice. If you would like to hire Sir Peter John Ratcliffe to deliver a keynote speech for your event, please fill out the contact form or email us at info@aurumbureau.com with as much detail as possible. One of our experienced agents will get in touch with you and let you know exactly how much it will cost to book Sir Peter John Ratcliffe.
How can I contact Sir Peter John Ratcliffe?
We only work with Sir Peter John Ratcliffe on paid speaking engagements. Aurum Speakers Bureau can assist you in booking Sir Peter John Ratcliffe and will handle all negotiations, contracts, and logistics associated with having Sir Peter John Ratcliffe speak at your event. We will be your sole point of contact throughout the process. Get in touch with Aurum Speakers Bureau today, and we will reach out to any motivational speaker or celebrity you want to enquire about speaking at your event. If you wish to contact Sir Peter John Ratcliffe for any other reason, we will be unable to assist you as we are not authorized to provide personal contact information.
Can I book Sir Peter John Ratcliffe for a virtual keynote?
Yes, Sir Peter John Ratcliffe is available for virtual keynotes and webinars. To book Sir Peter John Ratcliffe for a virtual event, please complete the contact form or send us an email to inquire about the special fees for virtual engagements.
